Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TAL1 anticorps

TAL1 Reactivité: Humain WB, ELISA, Coat Hôte: Souris Monoclonal BTL73 unconjugated
N° du produit ABIN6940681
  • Antigène Voir toutes TAL1 Anticorps
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Reactivité
    • 80
    • 37
    • 27
    • 6
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Humain
    Hôte
    • 84
    • 6
    Souris
    Clonalité
    • 85
    • 5
    Monoclonal
    Conjugué
    • 49
    • 7
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TAL1 est non-conjugé
    Application
    • 64
    • 43
    • 13
    • 9
    • 7
    • 7
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Coating (Coat)
    Purification
    Purified by Protein A/G
    Immunogène
    Recombinant human full-length TAL1 protein
    Clone
    BTL73
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product TAL1 Anticorps primaire
  • Indications d'application

    Positive Control: A549 xenograft.

    Known Application: ELISA (For coating, order antibody without BSA), Western Blot (0.5-1.0 μg/mL), Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Date de péremption
    24 months
  • Antigène
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Autre désignation
    TAL1 (TAL1 Produits)
    Synonymes
    anticorps SCL/tal-1, anticorps Scl, anticorps bHLHa17, anticorps tal-1, anticorps SCL, anticorps TCL5, anticorps scl, anticorps tcl5, anticorps SCL-alpha, anticorps SCL-beta, anticorps scl/tal1, anticorps zgc:85605, anticorps T cell acute lymphocytic leukemia 1, anticorps TAL bHLH transcription factor 1, erythroid differentiation factor, anticorps T-cell acute lymphocytic leukemia 1 S homeolog, anticorps T-cell acute lymphocytic leukemia 1, anticorps Tal1, anticorps TAL1, anticorps tal1.S, anticorps tal1
    Sujet
    Activation of TAL1 characterizes up to 60 % of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase IIHLH transcription factors.
    Poids moléculaire
    42kDa
    ID gène
    6886
    UniProt
    P17542
    Pathways
    Stem Cell Maintenance
Vous êtes ici:
Support technique